Parallax Health Sciences Inc (PRLX) Return on Investment ROI from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Parallax Health Sciences Inc   (PRLX)


Parallax Health Sciences Inc's ROI from its fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Parallax Health Sciences Inc's ROI in the fourth quarter of 2019?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Parallax Health Sciences Inc 's return on investment (ROI) in its fourth quarter of 2019

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -6 -3 -4 -4 -3
Return On Investment (TTM) - - - - -
PRLX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - 7.5 % 14.1 % 12.01 %
Net Income (TTM) in Millions -13 -9 19 18 15

PRLX Company Profile >> Back to PRLX Roi Comparisons >> See Annual PRLX Return On Investment



Return On Investment PRLX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Parallax Health Sciences Inc's IV. Quarter Investments $ -6 Millions PRLX's Balance sheet
Parallax Health Sciences Inc's IV. Quarter Income $ -6 Millions Quarterly PRLX's Income Statement
PRLX's Income by Division See PRLX's Income by Division


PRLX Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions -6 -4 -5 -2 5
Y / Y Investment Growth - - - - -
Net Income in Millions -13 15 -14 -13 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -71.05 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRLX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRLX's Competitors
Subscribers only: Roi for Parallax Health Sciences Inc's Suppliers
Subscribers only: Return On Investment for PRLX's Customers

Other Ratios
PRLX's Roa PRLX's Inventory Turnover Ratio PRLX's Growth Rates PRLX's Dividend Statistics
PRLX's Profitability Ratios PRLX's Asset Turnover Ratio PRLX's Dividend Growth
PRLX's Roe PRLX's Valuation Ratios PRLX's Financial Strength Ratios PRLX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2019, within Healthcare Sector ROI
Zomedica Corp   611.96 %
Tuhura Biosciences Inc   489.26 %
Exagen Inc   472.18 %
Oyster Point Pharma Inc   457.62 %
Black Diamond Therapeutics Inc   398.87 %
Trillium Therapeutics Inc   359.16 %
Xbiotech Inc   288.29 %
Progyny Inc   282.27 %
Check Cap Ltd  208.78 %
Quoin Pharmaceuticals Ltd   166.78 %
Semler Scientific inc   152.40 %
Tenax Therapeutics Inc   113.26 %
Rapt Therapeutics Inc   98.39 %
Altamira Therapeutics Ltd   89.97 %
Morphic Holding inc   84.53 %
Jounce Therapeutics inc   69.85 %
Orgenesis Inc   68.81 %
Molecular Templates Inc   65.27 %
Novo Nordisk A  58.34 %

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.